Neuronetics Unveils New Depression Data at Clinical TMS Society’s Virtual Events
September 22, 2020 08:00 ET
|
Neuronetics
MALVERN, Pa., Sept. 22, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Reports Second Quarter 2020 Financial and Operating Results
August 04, 2020 07:30 ET
|
Neuronetics
MALVERN, Pa., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics to Report Second Quarter 2020 Financial and Operating Results and Host Conference Call
July 21, 2020 08:00 ET
|
Neuronetics
MALVERN, Pa., July 21, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics to Present at the William Blair 40th Annual Growth Stock Conference
June 04, 2020 16:30 ET
|
Neuronetics
MALVERN, Pa., June 04, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Recognizes Critical Health Professionals During Mental Health Awareness Month
May 07, 2020 08:00 ET
|
Neuronetics
MALVERN, Pa., May 07, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics to Report First Quarter 2020 Financial and Operating Results and Host Conference Call
April 21, 2020 08:00 ET
|
Neuronetics
MALVERN, Pa., April 21, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Recognized as 2020 Top Neurology Device Provider
March 30, 2020 07:30 ET
|
Neuronetics
Company acknowledged on Top 10 List by MedTech Outlook Magazine MALVERN, Pa., March 30, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company...
Neuronetics® Hits Major Milestones with More Than 2.5 Million Treatments and 1,000 Installations of Its NeuroStar® Advanced Therapy System
March 16, 2020 07:30 ET
|
Neuronetics
MALVERN, Pa., March 16, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
FDA Grants NeuroStar® Advanced Therapy System Breakthrough Device Designation to Treat Bipolar Depression
March 06, 2020 07:30 ET
|
Neuronetics
MALVERN, Pa., March 06, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Reports Fourth Quarter and Full Year 2019 Financial and Operating Results
March 03, 2020 06:00 ET
|
Neuronetics
MALVERN, Pa., March 03, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...